Interline Therapeutics lands $92m to map, correct dysfunctional proteins
The company reportedly will utilize the investment funding to expand its research platform, and to advance six of its preclinical therapeutic programs.
Archives for May 13, 2021
Drug developer uses RWE to research psychedelic therapies
The UK-based development and research firm hopes to accelerate patient access to psychedelic therapies for treatment of various mental health conditions.
Cancer drug developer aims to elevate treatment
A leader from clinical-stage pharma firm NuCana shares promising results for its ProTides therapies and hopes the drugs can elevate outcomes for patients.